Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)

NAActive, not recruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Addiction, Opioid
Interventions
OTHER

Enhanced Monitoring and Feedback (EMF)

Enhanced Monitoring and Feedback consists of performance data (reach, adoption, effectiveness, implementation) gathered and reported by the program on a quarterly basis. Data summaries for each program and in comparison to the entire sample, will be reflected back to participants, via dashboards, within one-month of data submission.

OTHER

NIATx/MAT Academy

This two-day workshop will provide participating clinics with rationale, clinical practice and program integration with MOUD (Day 1), and an overview of NIATx principles and tools (Day 2).

OTHER

NIATx-Internal Facilitation (NIATx-IF)

Internal facilitators will receive training (in-person or online) on how to provide coaching within their organization. For 9-months, Internal Facilitators (IFs) will: a) support teams to harness resources toward systemic change and improvement; b) employ a range of concepts and tools to provide individualized support to teams; c) help teams to practice and hone their skills to optimize performance, and d) focus on team relationships and communications.

OTHER

NIATx-External Facilitation (NIATx-EF)

For 9-months, organizations in the NIATx-EF study arm will work with one of 4 experienced consultant NIATx External Facilitators (EFs). The EF meets with clinic staff to plan change projects, review ongoing change efforts, discuss successes, and offer guidance on planning future change projects using PDSA cycles. The EF makes a 1-day site visit during the 1st quarter of the implementation period and leads monthly 1-hour phone calls.

Trial Locations (1)

98501

Washington State Healthcare Authority, Olympia

All Listed Sponsors
collaborator

University of Wisconsin, Madison

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Washington State Health Care Authority

UNKNOWN

lead

Stanford University

OTHER